SecBot SecBot
144 ·Filed Jul 1, 2026

JAZZ

Jazz Pharmaceuticals plc
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001628280-26-046482
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This appears to be a routine pre-planned sale under a 10b5-1 plan. No material concern for the stock. Monitor for any acceleration of insider selling beyond the established monthly pattern.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
JAZZ ▼ -0.52% at T+60d
NEUTRAL call -0.52% · α vs SPY -3.47% · entry $237.51 → $236.28
Entry = T+0 close
Jul 1, 2026
via day close
T+1d
+2.51%
call +2.51% · α +2.64%
$243.47
settled 4mo ago
T+5d
+4.30%
call +4.30% · α +4.04%
$247.72
settled 4mo ago
T+20d
+7.77%
call +7.77% · α +9.96%
$255.97
settled 3mo ago
T+60d
-0.52%
call -0.52% · α -3.47%
$236.28
settled 4w ago

Price Chart

Loading chart...

Executive Summary

Officer Bruce C. Cozadd filed a Form 144 to sell 6,000 shares of Jazz Pharmaceuticals common stock, valued at approximately $1.44 million. This is part of a recurring monthly sale pattern (similar sales in April, May, and June 2026), likely under a pre-arranged trading plan. The sale is immaterial relative to the company's $15.1B market cap and does not signal a change in business fundamentals.

Key Facts

  • Bruce C. Cozadd (officer) filed Form 144 to sell 6,000 shares of common stock.
  • Estimated sale value: $1,442,820 based on recent market price.
  • Shares were acquired via stock option exercises in 2018 and 2019.
  • Similar 6,000-share sales occurred in April, May, and June 2026, indicating a recurring pattern.

Financial Impact

Sale of 6,000 shares (~$1.44M) represents ~0.0095% of market cap; negligible impact.

dilution

Risk Factors

  • None material from this filing; insider selling pattern is consistent and small.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (25 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-046482
Document: 0001628280-26-046482-index.html0001628280-26-046482
Document: 0001628280-26-046482.txt0001628280-26-046482
28 reports for JAZZ
Performance horizon
60% Hit rate @ T+1 3 of 5 directional calls Went positive at some point 4 of 5 best @ T+60▲ +22.04%Feb 24, 2026
Filters
Rows
Reports for JAZZ — sortable, filterable
TypeNow
Oct 19, 2026
6d ago
Press Release
NEUTRAL ★ 1/10
$213.76 $211.97▼ −0.84%▼ −1.36%$210.99 (−1.30%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$218.42 $216.75▼ −0.76%▼ −0.70%$210.99 (−3.40%)
Oct 8, 2026
17d ago
144
NEUTRAL ★ 2/10
$218.42 $216.75▼ −0.76%▼ −0.70%$210.99 (−3.40%)
Oct 6, 2026
19d ago
144
NEUTRAL ★ 2/10
$231.19 $222.45▼ −3.78%▼ −3.36%$210.99 (−8.74%)
Oct 1, 2026
24d ago
144
NEUTRAL ★ 2/10
$235.67 $236.04▲ +0.16%▼ −0.52%$210.99 (−10.47%)
Sep 15, 2026
5w ago
8-K
BULLISH ★ 6/10
$240.83 $243.59▲ +1.15%▲ +1.59%$210.99 (−12.39%)
Sep 14, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$240.83 $243.59▲ +1.15%▲ +1.59%$210.99 (−12.39%)
Sep 10, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$245.80 $245.87▲ +0.03%▲ +0.47%$210.99 (−14.16%)
Sep 2, 2026
7w ago
Insider Cluster
BEARISH ★ 4/10
$247.57 $246.81▲ +0.30%▼ −0.08%$210.99 (+14.78%)
Aug 31, 2026
7w ago
144
NEUTRAL ★ 2/10
$243.71 $245.57▲ +0.76%▲ +0.32%$210.99 (−13.43%)
Showing 10 of 28

US Market Status

Market Open — Closes in 5h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 1, 2026